Wockhardt US unit gets FDA warning notePost published:March 1, 2017Post category:Industry NewsProducts of Wockhardt’s US unit Morton Grove Pharma will be available in that market but new approvals will be withheld until compliance issues are resolved Source: Livemint.com (http://www.livemint.com/rss/industry)Read more articles Previous PostMasterCard eyes 1 million traders on its BharatQR platform Next PostYahoo chief counsel exits after hack probe finds inaction You Might Also Like Large Frame, Two Laser System for Polymer Parts in the Aerospace, Electronics and Mobility Industries April 23, 2018 Wi-Fi may spoil mobile internet’s party July 7, 2017 Anomaly Detection: Industrial Asset Insights Without Historical Data May 3, 2019
Large Frame, Two Laser System for Polymer Parts in the Aerospace, Electronics and Mobility Industries April 23, 2018